31.2 C
Jammu
Sunday, May 29, 2022

CATEGORY

Science n Tech

Covid booster dose effective in reducing severe disease outcomes: Lancet study

Boston: A third dose of COVID-19 vaccine is effective in reducing severe disease outcomes compared to individuals who have received two doses at least...

COVID-19 can be transmitted by fully vaccinated people at home: Lancet study

London: Fully vaccinated people can contract and pass on Delta variant of SARS-CoV-2, the virus that causes COVID-19, in household settings, but at lower...

India successfully flight-tests ABHYAS off Odisha coast

BALASORE: India Friday successfully flight-tested the endogenously developed High-speed Expendable Aerial Target (HEAT), ABHYAS, was successfully from the Integrated Test Range (ITR), Chandipur off the...

PM launches ‘Indian Space Association’, landmark breakthrough for ISRO

STATE TIMES NEWS NEW DELHI: In a landmark breakthrough, Prime Minister Narendra Modi on Monday launched Indian Space Association (ISpA) via video conferencing.Among those present...

Bharti’s OneWeb, ISRO arm collaborate to launch satellite in India from 2022

New Delhi: Bharti Group backed OneWeb on Monday said it has entered an arrangement with the commercial arm of ISRO, NewSpace India Limited (NSIL),...

PM to launch Indian Space Association on Monday

NEW DELHI: Prime Minister Narendra Modi will launch Indian Space Association (ISpA), an industry body aspiring to be the voice of the Indian space sector,...

Facebook, Instagram, WhatsApp coming back online after hours of disruption

Washington: Services of Facebook, Instagram, and WhatsApp are coming back online after several hours of disruption that impacted millions of people worldwide. While the users...

Facebook, WhatsApp, Instagram face global outage

STATE TIMES NEWS New Delhi: Facebook, WhatsApp and Instagram faced a major global outage on Monday evening with thousands of users, including from India, not...

WHO recommends antibody treatment for critical Covid patients

New Delhi: COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according...

COVID-19 may be linked to risk of Guillain-Barre syndrome: Study

London: Infection with the virus that causes COVID-19 may be associated with risk of developing Guillain-Barre syndrome, a disorder in which a person's immune...

Latest news